Lehman Brothers UK Capital Funding LP
24.2.2026 16:03:46 CET | Globenewswire | Press release
Lehman Brothers UK Capital Funding LP: Notice of Interim Payment
Lehman Brothers UK Capital Funding LP: Notice of Interim Payment
LONDON, Feb. 24, 2026 (GLOBE NEWSWIRE) --
NOTICE TO THE HOLDERS OF:
EUR 225,000,000 FIXED RATE TO CMS-LINKED GUARANTEED NON-VOTING, NON-CUMULATIVE PERPETUAL PREFERRED SECURITIES ("LP I Securities")
ISSUER: LEHMAN BROTHERS UK CAPITAL FUNDING LP ("LP I")
ISIN: XS0215349357
LIQUIDATION OF LB GP NO.1 LTD ("the Company") AND IMPLICATIONS FOR HOLDERS OF LP I SECURITIES
THIS NOTICE CONTAINS IMPORTANT INFORMATION THAT IS OF INTEREST TO THE REGISTERED AND BENEFICIAL OWNERS OF THE SUBJECT SECURITIES. IF APPLICABLE, ALL DEPOSITORIES, CUSTODIANS AND OTHER INTERMEDIARIES RECEIVING THIS NOTICE ARE REQUESTED TO EXPEDITE THE RE-TRANSMITTAL TO BENEFICIAL OWNERS OF THE SECURITIES IN A TIMELY MANNER.
Your attention is drawn to the formal notice contained in the PDF link below concerning the Company, LP I and the LP I Securities. In order to view the formal notice, it is recommended that you copy and paste the link into your browser.
http://www.rns-pdf.londonstockexchange.com/rns/2191U_1-2026-2-24.pdf
If you have any difficulties in opening the link, please contact Samantha Hawkins at RSM UK Restructuring Advisory LLP by e-mail: Samantha.Hawkins@rsmuk.com.
Dated: 24 February 2026
This notice is given by
Matthew Haw
RSM UK Restructuring Advisory LLP
as Joint Liquidator of LB GP No.1 Ltd
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Countdown For A Cure24.2.2026 18:57:08 CET | Press release
Countdown For A Cure Raises Over $1 Million at 2026 Evening of Energy Gala
Cosmos Health Inc.24.2.2026 18:30:00 CET | Press release
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Biotalys NV24.2.2026 18:00:00 CET | Press release
Biotalys Notice of Publication 2025 Annual Report and Financial Results
IPSOS24.2.2026 17:52:57 CET | Press release
[Press Release] 2025 results in line with guidance - Launch of Horizons strategic plan
Marimekko Corporation24.2.2026 17:45:00 CET | Press release
Marimekko Corporation: Repurchase of own shares on 24 February 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom